Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Milligan, G; Kellett, E; Dacquet, C; Dubreuil, V; Jacoby, E; Millan, MJ; Lavielle, G; Spedding, M
   S 14506: novel receptor coupling at 5-HT1A receptors
   NEUROPHARMACOLOGY
   
   G. Milligan et al., "S 14506: novel receptor coupling at 5-HT1A receptors", NEUROPHARM, 40(3), 2001, pp. 334-344
2. Cayatte, AJ; Du, Y; Oliver-Krasinski, J; Lavielle, G; Verbeuren, TJ; Cohen, RA
   The thromboxane receptor antagonist S18886 but not aspirin inhibits atherogenesis in apo E-deficient mice - Evidence that eicosanoids other than thromboxane contribute to atherosclerosis
   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
   
   A.J. Cayatte et al., "The thromboxane receptor antagonist S18886 but not aspirin inhibits atherogenesis in apo E-deficient mice - Evidence that eicosanoids other than thromboxane contribute to atherosclerosis", ART THROM V, 20(7), 2000, pp. 1724-1728
3. Millan, MJ; Gobert, A; Newman-Tancredi, A; Lejeune, F; Cussac, D; Rivet, JM; Audinot, V; Dubuffet, T; Lavielle, G
   S33084, a novel, potent, selective, and competitive antagonist at dopamineD-3-receptors: I. Receptorial, electrophysiological and neurochemical profile compared with GR218,231 and L741,626
   JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
   
   M.J. Millan et al., "S33084, a novel, potent, selective, and competitive antagonist at dopamineD-3-receptors: I. Receptorial, electrophysiological and neurochemical profile compared with GR218,231 and L741,626", J PHARM EXP, 293(3), 2000, pp. 1048-1062
4. Millan, MJ; Dekeyne, A; Rivet, JM; Dubuffet, T; Lavielle, G; Brocco, M
   S33084, a novel, potent, selective, and competitive antagonist at dopamineD-3-receptors: II. Functional and behavioral profile compared with GR218,231 and L741,626
   JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
   
   M.J. Millan et al., "S33084, a novel, potent, selective, and competitive antagonist at dopamineD-3-receptors: II. Functional and behavioral profile compared with GR218,231 and L741,626", J PHARM EXP, 293(3), 2000, pp. 1063-1073
5. Dubuffet, T; Newman-Tancredi, A; Cussac, D; Audinot, V; Loutz, A; Millan, MJ; Lavielle, G
   Novel benzopyrano[3,4-c]pyrrole derivatives as potent and selective dopamine D-3 receptor antagonists
   BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
   
   T. Dubuffet et al., "Novel benzopyrano[3,4-c]pyrrole derivatives as potent and selective dopamine D-3 receptor antagonists", BIOORG MED, 9(14), 1999, pp. 2059-2064
6. Dubuffet, T; Loutz, A; Lavielle, G
   An efficient large scale synthesis of coumarins by a dealkylative boron-mediated ring closure of 3-(orthomethoxyaryl)propenoic esters.
   SYNTHETIC COMMUNICATIONS
   
   T. Dubuffet et al., "An efficient large scale synthesis of coumarins by a dealkylative boron-mediated ring closure of 3-(orthomethoxyaryl)propenoic esters.", SYN COMMUN, 29(6), 1999, pp. 929-936
7. CIMETIERE B; DUBUFFET T; LANDRAS C; DESCOMBES JJ; SIMONET S; VERBEUREN TJ; LAVIELLE G
   NEW TETRAHYDRONAPHTHALENE DERIVATIVES AS COMBINED THROMBOXANE RECEPTOR ANTAGONISTS AND THROMBOXANE SYNTHASE INHIBITORS
   Bioorganic & medicinal chemistry letters
   
   B. Cimetiere et al., "NEW TETRAHYDRONAPHTHALENE DERIVATIVES AS COMBINED THROMBOXANE RECEPTOR ANTAGONISTS AND THROMBOXANE SYNTHASE INHIBITORS", Bioorganic & medicinal chemistry letters, 8(11), 1998, pp. 1381-1386
8. MILLAN MJ; GOBERT A; NEWMANTANCREDI A; AUDINOT V; LEJEUNE F; RIVET JM; CUSSAC D; NICOLAS JP; MULLER O; LAVIELLE G
   S-16924 YL]-PYRROLIDIN-3YL)-1-(4-FLUORO-PHENYL)-ETHANONE), A NOVEL POTENTIAL ANTIPSYCHOTIC WITH MARKED SEROTONIN (5-HT)(1A) AGONIST PROPERTIES - I - RECEPTORIAL AND NEUROCHEMICAL PROFILE COMPARISON WITH CLOZAPINE AND HALOPERIDOL
   The Journal of pharmacology and experimental therapeutics
   
   M.J. Millan et al., "S-16924 YL]-PYRROLIDIN-3YL)-1-(4-FLUORO-PHENYL)-ETHANONE), A NOVEL POTENTIAL ANTIPSYCHOTIC WITH MARKED SEROTONIN (5-HT)(1A) AGONIST PROPERTIES - I - RECEPTORIAL AND NEUROCHEMICAL PROFILE COMPARISON WITH CLOZAPINE AND HALOPERIDOL", The Journal of pharmacology and experimental therapeutics, 286(3), 1998, pp. 1341-1355
9. MILLAN MJ; SCHREIBER R; DEKEYNE A; RIVET JM; BERVOETS K; MAVRIDIS M; SEBBAN C; MAURELREMY S; NEWMANTANCREDI A; SPEDDING M; MULLER O; LAVIELLE G; BROCCO M
   S-16924 YL]-PYRROLIDIN-3YL)-1-(4-FLUORO-PHENYL)-ETHANONE), A NOVEL, POTENTIAL ANTIPSYCHOTIC WITH MARKED SEROTONIN (5-HT)(1A) AGONIST PROPERTIES - II - FUNCTIONAL PROFILE IN COMPARISON TO CLOZAPINE AND HALOPERIDOL
   The Journal of pharmacology and experimental therapeutics
   
   M.J. Millan et al., "S-16924 YL]-PYRROLIDIN-3YL)-1-(4-FLUORO-PHENYL)-ETHANONE), A NOVEL, POTENTIAL ANTIPSYCHOTIC WITH MARKED SEROTONIN (5-HT)(1A) AGONIST PROPERTIES - II - FUNCTIONAL PROFILE IN COMPARISON TO CLOZAPINE AND HALOPERIDOL", The Journal of pharmacology and experimental therapeutics, 286(3), 1998, pp. 1356-1373
10. CAYATTE AJ; DU Y; YAGHOUBI M; OLIVERKRASINSKI J; LAVIELLE G; VERHEUREN TJ; COHEN RA
    THE THROMBOXANE A(2) RECEPTOR ANTAGONIST, S18886, DECREASES ATHEROSCLEROTIC LESIONS AND SERUM INTRACELLULAR ADHESION MOLECULE-1 IN THE APO-E KNOCKOUT MOUSE
    Circulation
    
    A.J. Cayatte et al., "THE THROMBOXANE A(2) RECEPTOR ANTAGONIST, S18886, DECREASES ATHEROSCLEROTIC LESIONS AND SERUM INTRACELLULAR ADHESION MOLECULE-1 IN THE APO-E KNOCKOUT MOUSE", Circulation, 98(17), 1998, pp. 590-590
11. VERBEUREN T; DESCOMBES JJ; SIMONET S; DUBUFFET T; LAVIELLE G
    THE TP-RECEPTOR ANTAGONIST S-18886 UNMASKS VASCULAR RELAXATION AND POTENTIATES THE ANTIPLATETLET ACTION OF PGD(2)
    Thrombosis and haemostasis
    
    T. Verbeuren et al., "THE TP-RECEPTOR ANTAGONIST S-18886 UNMASKS VASCULAR RELAXATION AND POTENTIATES THE ANTIPLATETLET ACTION OF PGD(2)", Thrombosis and haemostasis, 1997, pp. 2826-2826
12. DUBUFFET T; CIMETIERE B; LAVIELLE G
    A CONVENIENT SYNTHESIS OF 2H-PYRAN-2-ONE DERIVATIVES
    Synthetic communications
    
    T. Dubuffet et al., "A CONVENIENT SYNTHESIS OF 2H-PYRAN-2-ONE DERIVATIVES", Synthetic communications, 27(7), 1997, pp. 1123-1131
13. NEWMANTANCREDI A; CONTE C; CHAPUT C; VERRIELE L; AUDINOTBOUCHEZ V; LOCHON S; LAVIELLE G; MILLAN MJ
    AGONIST ACTIVITY OF ANTIMIGRAINE DRUGS AT RECOMBINANT HUMAN 5-HT1A RECEPTORS - POTENTIAL IMPLICATIONS FOR PROPHYLACTIC AND ACUTE THERAPY
    Naunyn-Schmiedeberg's archives of pharmacology
    
    A. Newmantancredi et al., "AGONIST ACTIVITY OF ANTIMIGRAINE DRUGS AT RECOMBINANT HUMAN 5-HT1A RECEPTORS - POTENTIAL IMPLICATIONS FOR PROPHYLACTIC AND ACUTE THERAPY", Naunyn-Schmiedeberg's archives of pharmacology, 355(6), 1997, pp. 682-688
14. AUDINOT V; LOCHON S; NEWMANTANCREDI A; LAVIELLE G; MILLAN MJ
    BINDING PROFILE OF THE NOVEL 5-HT1B 1D RECEPTOR ANTAGONIST, [H-3] GR-125,743, IN GUINEA-PIG BRAIN - A COMPARISON WITH [H-3] 5-CARBOXAMIDOTRYPTAMINE/
    European journal of pharmacology
    
    V. Audinot et al., "BINDING PROFILE OF THE NOVEL 5-HT1B 1D RECEPTOR ANTAGONIST, [H-3] GR-125,743, IN GUINEA-PIG BRAIN - A COMPARISON WITH [H-3] 5-CARBOXAMIDOTRYPTAMINE/", European journal of pharmacology, 327(2-3), 1997, pp. 247-256
15. MILLAN MJ; PEGLION JL; LAVIELLE G; PERRINMONNEYRON S
    5-HT2C RECEPTORS MEDIATE PENILE ERECTIONS IN RATS - ACTIONS OF NOVEL AND SELECTIVE AGONISTS AND ANTAGONISTS
    European journal of pharmacology
    
    M.J. Millan et al., "5-HT2C RECEPTORS MEDIATE PENILE ERECTIONS IN RATS - ACTIONS OF NOVEL AND SELECTIVE AGONISTS AND ANTAGONISTS", European journal of pharmacology, 325(1), 1997, pp. 9-12
16. VERBEUREN TJ; VALLEZ MO; LAVIELLE G; BOUSKELA E
    ACTIVATION OF THROMBOXANE RECEPTORS AND THE INDUCTION OF VASOMOTION IN THE HAMSTER-CHEEK POUCH MICROCIRCULATION
    British Journal of Pharmacology
    
    T.J. Verbeuren et al., "ACTIVATION OF THROMBOXANE RECEPTORS AND THE INDUCTION OF VASOMOTION IN THE HAMSTER-CHEEK POUCH MICROCIRCULATION", British Journal of Pharmacology, 122(5), 1997, pp. 859-866
17. DESCOMBES JJ; MENANT Y; LAVIELLE G; VERBEUREN TJ
    BINDING-PROPERTIES OF A POTENT, LONG-ACTING NEW THROMBOXANE RECEPTOR ANTAGONIST, [H-3]S-18886, ON HUMAN, RAT AND DOG PLATELET MEMBRANE
    British Journal of Pharmacology
    
    J.J. Descombes et al., "BINDING-PROPERTIES OF A POTENT, LONG-ACTING NEW THROMBOXANE RECEPTOR ANTAGONIST, [H-3]S-18886, ON HUMAN, RAT AND DOG PLATELET MEMBRANE", British Journal of Pharmacology, 122, 1997, pp. 381-381
18. DUBUFFET T; MULLER O; SIMONET SS; DESCOMBES JJ; LAUBIE M; VERBEUREN TJ; LAVIELLE G
    SYNTHESIS OF NEW 3,4-DISUBSTITUTED PYRROLIDINES AS THROMBOXANE A(2) PROSTAGLANDIN H-2 (TP) RECEPTOR ANTAGONISTS
    Bioorganic & medicinal chemistry letters
    
    T. Dubuffet et al., "SYNTHESIS OF NEW 3,4-DISUBSTITUTED PYRROLIDINES AS THROMBOXANE A(2) PROSTAGLANDIN H-2 (TP) RECEPTOR ANTAGONISTS", Bioorganic & medicinal chemistry letters, 6(4), 1996, pp. 349-352
19. VERBEUREN TJ; SIMONET S; DESCOMBES JJ; VALLEZ MO; LAUBIE M; LAVIELLE G
    S-18204 - A NEW POWERFUL TXA(2)-RECEPTOR ANTAGONIST WITH A LONG-DURATION OF ACTION
    Thrombosis and haemostasis
    
    T.J. Verbeuren et al., "S-18204 - A NEW POWERFUL TXA(2)-RECEPTOR ANTAGONIST WITH A LONG-DURATION OF ACTION", Thrombosis and haemostasis, 73(6), 1995, pp. 1324-1324
20. MILLAN MJ; AUDINOT V; BROCCO M; MAURELREMY S; JOLY F; NEWMANTANCREDI A; CANTON H; HAUTEFAYE P; SPEDDING M; MULLER O; LAVIELLE G
    S-16924 - A PYRROLIDINE-SUBSTITUTED BENZODIOXANE WITH HIGHER AFFINITYAT 5-HT1A 2A/2C THAN D2 RECEPTORS, AND AN ATYPICAL ANTIPSYCHOTIC PROFILE IN THE RAT/
    British Journal of Pharmacology
    
    M.J. Millan et al., "S-16924 - A PYRROLIDINE-SUBSTITUTED BENZODIOXANE WITH HIGHER AFFINITYAT 5-HT1A 2A/2C THAN D2 RECEPTORS, AND AN ATYPICAL ANTIPSYCHOTIC PROFILE IN THE RAT/", British Journal of Pharmacology, 114, 1995, pp. 156-156